<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR113">
 <label>113</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chiba</surname>
    <given-names>Yukino</given-names>
   </name>
   <name>
    <surname>Mizoguchi</surname>
    <given-names>Izuru</given-names>
   </name>
   <name>
    <surname>Mitobe</surname>
    <given-names>Kana</given-names>
   </name>
   <name>
    <surname>Higuchi</surname>
    <given-names>Kaname</given-names>
   </name>
   <name>
    <surname>Nagai</surname>
    <given-names>Hiroshi</given-names>
   </name>
   <name>
    <surname>Nishigori</surname>
    <given-names>Chikako</given-names>
   </name>
   <name>
    <surname>Mizuguchi</surname>
    <given-names>Junichiro</given-names>
   </name>
   <name>
    <surname>Yoshimoto</surname>
    <given-names>Takayuki</given-names>
   </name>
  </person-group>
  <article-title>IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner</article-title>
  <source>PLoS ONE</source>
  <year>2013</year>
  <volume>8</volume>
  <issue>10</issue>
  <fpage>e76159</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0076159</pub-id>
  <?supplied-pmid 24155891?>
  <pub-id pub-id-type="pmid">24155891</pub-id>
 </element-citation>
</ref>
